Jeffery Smisek - Jun 13, 2022 Form 4 Insider Report for Finch Therapeutics Group, Inc. (FNCH)

Role
Director
Signature
By: /s/ Joseph Vittiglio, Attorney-in-Fact
Stock symbol
FNCH
Transactions as of
Jun 13, 2022
Transactions value $
$0
Form type
4
Date filed
6/15/2022, 05:02 PM
Next filing
Jun 9, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FNCH Stock Option (right to buy) Award $0 +44.8K $0.00 44.8K Jun 13, 2022 Common Stock 44.8K $2.79 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this option shall vest in twelve equal monthly installments beginning on July 13, 2022, subject to the Reporting Person continuing to provide service through each such date.